This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
LivaNova CFO Thad Huston's resignation comes as activist investor PrimeStone Capital has been urging the company to make some big changes. Hiring a new CFO was, in fact, one of those changes.
The Salt Lake City, UT-based company won FDA approval to expand a clinical study of the Tria surgical aortic valve. The company raised $20 million in a series D round in June.
A medtech analyst suggests that the sum of LivaNova's parts are worth significantly more than its current value, and that value could be created by breaking up the company.
Study findings point out the device met the primary safety endpoint compared to historical controls but did not demonstrate superiority for the primary hierarchical efficacy endpoint.
Results from the SCOPE II trial were presented at TCT Connect and showed the Acurate Neo failed to demonstrate non-inferiority when compared to Medtronic’s CoreValve Evolut.